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Signaling through the T cell receptor for antigen (TCR) has been studied for years by conventional
biochemical means. More recently, attempts have been made to develop computational models of
signaling through this receptor, with a speciﬁc focus on understanding how this recognition system
discriminates between closely related (self and non-self) ligands. Here we discuss recent advances
centered on the role of feedback regulation, especially the key ﬁnding that a combination of digital
and analog control circuits is fundamental to the discrimination properties of the TCR. We end by
pointing to future, more biologically accurate models that incorporate spatial aspects of molecular
organization in antigen-engaged T lymphocytes with this underlying biochemistry.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
For more than a quarter of a century, beginning with the initial
studies of Stobo and co-workers showing that IP3 generation and
Ca2+ inﬂux accompanied antibody crosslinking of the CD3 complex
of human T cells [1,2], immunologists have probed the mechanistic
underpinnings of immune recognition and signal transduction in T
lymphocytes. Progress has included identiﬁcation of peptides
bound to the surface proteins encoded by the Major Histocompat-
ibility Complex Class I and Class II loci (pMHC) as the proximate li-
gands for T cell immune recognition [3–5], cloning of the variable
subunits of the T cell receptor (TCR) that recognizes these pMHC
[6,7], description of the importance of the phosphorylation motifs
termed ITAMs that are present in multiple copies in the cytoplas-
mic tails of the CD3 components of the receptor complex [8,9],
uncovering of the role of the CD4 and CD8 coreceptors in
antigen-dependent signaling [10], and identiﬁcation and func-
tional analysis of a large universe of kinases, adapters, enzymes,
and target transcription factors that translate ligand engagement
into gene regulatory events that control T cell differentiation and
proliferation following antigen recognition [11–13].
Despite this impressive knowledge base, our insight into how
pMHC binding to the TCR actually triggers the earliest steps inlf of the Federation of European Bithe signaling cascade is more limited than might be expected, with
a number of competing hypotheses [14–19]. This same set of
hypotheses inform ongoing debates about how differences in bind-
ing afﬁnity or capacity for receptor allosteric change result in func-
tional discrimination between structurally similar pMHC ligands
by any individual TCR. The large body of imaging data showing
marked surface molecule re-organization (microclusters and
immunological synapse formation) during the signaling process
[20–23] has yet to be placed in a robust conceptual framework that
relates these changes to operation of the signaling apparatus and
the functional effects of ligand recognition on the T cell. Finally,
we know very little yet about how variations in the coupling of
the same TCR structure to the intracellular signaling machinery
during different stages of T cell development and differentiation al-
lows for distinct outcomes upon ligand binding, such that self-li-
gands can promote initiation of developmental progression
among thymocytes (positive selection) and yet be incapable of
gene activation in mature cells expressing the same recognition
structure and encountering the same self-pMHC [24,25].
Over the past few years, an increasing number of investigators
have turned to modeling and simulation (computational biology)
in an effort to better address these problems that have not been
satisfactorily approached by conventional cell biological and bio-
chemical methods. The majority of these efforts have focused
attention on the key questions of ligand discrimination and signal-
ing sensitivity that are characteristic of T cell antigen recognition.ochemical Societies.
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volve a robust combination of computation and experiment. Here
we discuss some of these efforts, especially what present models
have contributed to our understanding and what are some of the
limitations of the approaches taken to date. We then address
how we hope to markedly improve on these existing efforts in
the coming years using new computational tools, quantitative
and/or global measurement technologies, and multiple rounds of
prediction and experimental testing.2. The past
2.1. Kinetic proofreading as a core concept
The ﬁrst widely appreciated set of models for pMHC ligand dis-
crimination by the TCR developed out of the proposal that this
receptor system relied on kinetic proofreading to regulate effective
activation of the T cell [15]. The hypothesis was based on the no-
tion that progressing fully through a linked cascade of enzymatic
reactions required persistent occupancy of the TCR, given the
underlying assumption of an overriding level of tonic negative sig-
naling that returned the system to baseline as soon as ligand no
longer occupied the TCR. Short-lived binding events would not
provide enough time for the cascade of reactions to progress to
completion. Because the elements of the cascade were enzymes,
each step involved (potentially) a substantial amount of signal
ampliﬁcation. In turn, this would lead to very non-linear attenua-
tion of functional signaling if the input driving ﬂux through the
cascade was aborted before the ﬁnal steps occurred. The relation-
ship between small changes in the length of occupancy (basically,
a reﬂection of the dissociation rate between TCR and pMHC) was
thus proposed to be a power function and a few fold decrease in
binding strength would therefore be expected to result in a many
fold larger loss of effective signal propagation. Kinetic measure-
ments using surface plasmon resonance (SPR) and tetramer disso-
ciation experiments emerging at this time that showed only a few
seconds difference in the effective length of interaction between a
given TCR and a strong vs. a weak agonist whose potencies differed
by logs in terms of effective EC50 were consistent with this general
thesis [26–30] (but not all studies agreed with this view – see [31])
and several simple mathematical models that seemed to explain
the experimental ﬁndings were constructed based on this proof-
reading concept [32,33].
2.2. Antagonists raise questions about simple occupancy models
In the same time frame, concern developed over whether sim-
ple occupancy, even with the proofreading concept incorporated,
was adequate to explain TCR-ligand relationships. The discovery
of TCR antagonists was the key development in this area [34–37].
If all engagements of the TCR by pMHC ligand contributed to posi-
tive signaling events and it was the integrated sum of all such
occupancy events that drove signal generation, then all pMHC li-
gands for a given receptor should fall into two categories. The ﬁrst
would be agonists of varying potency, based solely on the duration
of occupancy. The second would be non-agonists, which in reality
are extremely weak agonists whose capacity for stimulation could
not be revealed experimentally because the maximally attainable
density of pMHC on an antigen presenting cell (APC) was simply
too low given a low afﬁnity for the TCR to engender enough aver-
age occupancy to yield a measurable response [38]. What clearly
should not be observed was antagonism – that is, the capacity of
a pMHC to inhibit the response to more potent pMHC presented
to the same T cell on the same APC membrane. This is because
the only way such antagonists could mediate a negative effectwould be to prevent occupancy of the TCR by the more potent li-
gand and they could only do so when occupying the TCR them-
selves. Thus, if all occupancy was equivalent, one would simply
be replacing one binding event with another and no change in
functional response should be seen. But in the early 1990s multiple
laboratories using both mouse and human cell models showed that
slight variations in the amino acid sequence of potent agonist pep-
tide could produce pMHC that inhibited responses to the parent
agonist pMHC co-presented on the same APC – that is, they func-
tioned as antagonists. Some early interpretations used the proof-
reading concept to develop a possible way out of this paradox
and retain the core features of a simple occupancy model. It was
suggested that in the context of a McKeithan-type proofreading
scheme, the antagonists occupied the TCR for too short a time to
produce an effective downstream signal, but at high concentra-
tions, they engaged so many TCR brieﬂy that they prevented the
agonist pMHC ligand from accessing as many TCR as would other-
wise be the case, thus limiting the overall effective stimulation of
the T cell [34].
Data from this laboratory, however, suggested that antagonists
might (also) operate through a more active mechanism [35] and
this concept was given substantial support by studies using T cells
from mice bred to express two distinct TCRs with different pMHC
speciﬁcities [39,40]. Using this experimental tool, it was demon-
strated that an antagonist to one TCR could antagonize responses
to an agonist that engaged the other TCR. Such a result could not
be explained by competitive occupancy, because the antagonist
pMHC did not bind the same TCR that could engage the agonist
pMHC offered on the same APC. These data provided evidence that
antagonism could operate in trans, that is, between different recep-
tors, and led to a search for molecular mechanisms that could ac-
count for this phenomenon.
Biochemical studies focused on active, TCR-induced, negative
regulatory pathways, as these seemed most likely to account for
such ﬁndings. The ﬁrst clues came from studies in this laboratory
and that of P. Allen, showing that antagonists were not null ligands
but were able to induce a proximal TCR signaling pattern of incom-
plete f chain ITAM phosphorylation and recruitment without phos-
phorylation of ZAP-70 kinase [41,42]. This pattern of early
signaling differed from the complete f phosphorylation and ZAP-
70 phosphorylation/activation characteristic of agonist engage-
ment of the TCR. The fact that the most proximal steps known in
the TCR signaling cascade were already altered upon antagonist
recognition, and the fact that some positive events, namely phos-
phorylation of some ITAM sequences in f, accompanied antagonist
engagement of the TCR, could be explained either by arguing that
the weak ligand could only produce a limited set of downstream
events a la McKeithan, or that such stimulation induced unopposed
negative feedback that prevented the full signaling response. If the
latter view was correct, then an adequate amount of such negative
regulatory function induced by large amounts of antagonist
engagement could inhibit responses to low amounts of pMHC ago-
nist provided to the T cell simultaneously. In a general sense, this
concept added to the McKeithan proofreading the action of nega-
tive feedback and suggested that such feedback could be induced
as a consequence of very early events in the cascade of positive
enzymatic steps he proposed. If this was the case, then persistent
engagement of the TCR by agonist pMHC in some manner allowed
the cell to override these negative effects. The simplest way for this
to happen would be for the ampliﬁcation that accompanied pro-
gression through the cascade to quantitatively override the level
of negative regulation induced by the smaller amount of signal
characteristic of early states of the cascade. The very high ratio of
antagonist to agonist necessary to reveal inhibitory activity could
then by ascribed a requirement for the summation of many inputs
feeding into the low level negative feedback loop to produce
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erated by a few agonists. Consistent with this hypothesis of a key
role for a negative feedback pathway, several groups then provided
direct evidence that the hematopoietic phosphatase SHP-1 was
crucial to antagonist function [39,43,44].
Negative feedback alone, though helping to explain TCR antag-
onism on a mechanistic basis, did not provide a full picture of how
ligand discrimination operated. A striking observation made in our
laboratory revealed that the ERK pathway directly modiﬁed Lck,
the key proximal kinase in the TCR signaling pathway, and that
inhibition of the ERK pathway resulted in conversion of the proxi-
mal signaling molecular signature from that of an agonist (fully
phosphorylated f and ZAP-70) to that of an antagonist (partially
phosphorylated f with docked but not active or phosphorylated
ZAP-70) [43]. These ﬁndings could not be explained based on a
simple ampliﬁcation proofreading scheme, but instead indicated
that a positive feedback event mediated by ERK was active in sup-
porting agonist signaling. Our studies thus revealed two intercon-
nected pathways that were sensitive to ligand quality (Fig. 1). The
hematopoietic cytosolic phosphatase SHP-1 was tyrosine phos-
phorylated at position 564 [45] and then bound to the SH2 domain
of Lck associated with the TCR complex (but not that Lck pool
bound to the CD4 co-receptor) on CD4+ T cells within a minute
of antagonist stimulation. In marked contrast, such binding of
TCR-associated Lck by pSHP-1 was not seen until after 30–
45 min of agonist signaling, in concert with an attenuation of f
phosphorylation and ZAP-70 activity at this time. Treatment of TFig. 1. Colored-coded diagram of the key biochemical events in the feedback
regulation of proximal TCR signaling. This cartoon illustrates the competing
negative (SHP-1 mediated) and positive (ERK-mediated) feedback loops that
sharpen TCR discrimination of pMHC ligands. p56Lck* = kinase active Lck.
p59Lck* = kinase active Lck serine phosphorylated on position 59. ppERK is
dually-phosphorylated, active ERK. pSHP-1 is tyrosine 564 phosphorylated SHP-1.
The signaling starts with the interaction of peptide-MHC ligands with the TCR,
which is coupled to the src-family kinase Lck in its p56 form. This leads to activation
of Lck to p56 Lck* (blue arrow). The active Lck tyrosine phosphorylates SHP-1,
producing pSHP-1, which in turn becomes activated within the phosphorylated
environment of the active receptor, leading to dephosphorylation of key compo-
nents of the signaling complex, including Lck itself, TCR f, and ZAP-70 (not shown).
This negative feedback pathway is indicated by red arrows and dominates with
poor ligands, explaining the lack of effective downstream signaling. TCR engage-
ment can also lead to signal propagation via Ras-GRP and SOS to ERK, producing
active ERK (ppERK), shown in green arrows. ppERK can phosphorylate TCR-
associated p56 Lck to produce p59 Lck (green arrows). This form of Lck is resistant
to recruitment of pSHP-1 (indicated by beige arrow with X). This active kinase (p59
Lck*) mediates prolonged signaling through the TCR complex that communicates
with various pathways leading to gene activation (not shown). This positive
feedback loop (inhibition of the negative SHP-1 feedback loop) dominates with
highly effective ligands and explains their potency.cells with a MEK inhibitor that prevented ERK activation allowed
the rapid binding of SHP-1 to Lck even in the presence of agonist,
consistent with the effect of this inhibitor on the pattern of f and
ZAP-70 phosphorylation. These ﬁndings indicted that weak ligands
predominantly evoked negative feedback regulation of TCR signal-
ing consisting of tyrosine phosphorylation of SHP-1 by activated
Lck, which led to binding of the phosphorylated phosphatase to
Lck in the TCR complex. Further tyrosine phosphorylation engaged
the SH2 domains of the SHP-1, activated the phosphatase and led
to loss of Lck activity, f phosphorylation, and ZAP-70 phosphoryla-
tion. These changes in turn shut down progressive signal transduc-
tion in the cascade leading to transcription factor activation, and
hence, prevented the T cell from becoming functionally activated
by ligands inducing this set of events alone. Agonists were able
to induce ERK activation and ERK led to serine 59 phosphorylation
of Lck, which prevented tyrosine phosphorylated SHP-1 from dock-
ing and hence, from mediating a negative effect on downstream
signaling. This accounted for why agonists were effective even
though pSHP-1 could still be formed by agonist signaling. These
ﬁndings provided important insight into the biochemical control
of TCR responses and suggested that the concatenation of two
feedback loops opposing one another contributed to sharpening
pMHC discrimination by the T cell (Fig. 1).3. The present – a new feedback regulation model built on a
proofreading framework
The biochemical evidence supporting the SHP-1 negative:ERK
positive feedback scheme was strong, but it did not lead to a rapid
adoption of this scheme by most of the ﬁeld as a critical aspect of
TCR signaling and ligand discrimination. In part, this hesitancy ar-
ose because the ERK effect is not readily seen when using antibod-
ies and transformed cells rather than non-transformed cells and
pMHC stimuli. Given that the bulk of TCR biochemical studies have
been and continue to be done using the former conditions [11,13],
it was not clear whether the data we generated was generally
applicable. However, a strong case can be made that results ob-
tained with normal cells and physiological ligands should be given
precedence over those arising from use of malignant cells and
unphysiological stimuli. A second reason for limited acceptance
was the claim that ERK, considered by the ﬁeld to be a key player
in nuclear gene activation events, was being proposed to regulate
upstream biochemical signaling by the TCR, something of a heret-
ical notion. Finally, on a more concrete basis, questions were raised
about how what was essentially a bimolecular interaction involv-
ing Lck and SHP-1 could be overridden by the ERK pathway, with
its many steps between TCR engagement and ppERK formation.
In particular, why wouldn’t the bimolecular pathway always dom-
inate kinetically and hence, biochemically?
To address this latter issue in particular, we undertook the
development of a new computational model of TCR signaling
[46,47], based on the SHP-1: ERK hypothesis and also on a recon-
sideration of the models that had been developed using the McKei-
than proofreading concept including one that included some of our
early data on these feedback pathways [48]. A re-analysis of the re-
sults from simulations using these earlier models revealed that
none adequately dealt at one time with three known characteris-
tics of the TCR signaling response to pMHC:
1. The response is very rapid. We and others have shown that
tyrosine phosphorylation of f and ZAP-70 occur within seconds
of T cell-APC contact and even at these early times, one can
detect the characteristic differences in phosphorylation
described above for antagonist vs. agonist pMHC ligands [41–
43]. Hence, any model that takes minutes of simulated time
Ligand concentration 






Fig. 2. Illustration of how classical Western blot analysis of signaling obscures
analog vs. digital behaviors in T cell activation and of the markedly different biology
that emerges in the two cases at the cell activation level. Red color intensity reports
on the level of measured signal in a given cell.
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ligand classes fails to capture an essential feature of the system.
2. The response is sensitive. Our data using direct detection of the
number of pMHC on the presenting cell [46], and data from sev-
eral other laboratories [49–51], all indicate that as few as 1 and
certainly as few as 10 good agonist pMHC can induce sustained
calcium inﬂux and other biochemical indicators of strong sig-
naling by T cells and in longer term assays, induce functional
responses. Thus, any model whose simulation requires hun-
dreds or thousands of pMHC to trigger a T cell is not properly
scaled to biological reality.
3. The response is highly discriminatory. A single amino acid side
chain alteration in the peptide can change the dose response
more than 20,000 fold, even though biophysical measurements
indicate only a few fold change in the binding kinetics between
the altered pMHC and the TCR that it engages, relative to the
kinetic parameters involving the more potent agonist (reviewed
in [47]). Any model that does not show such dramatic changes
in efﬁcacy for ligands with such a small difference in binding
potential doesn’t ﬁt with a key known property of this recogni-
tion/response system.
Our review of models that were based on McKeithan proofread-
ing without or with just negative feedback showed that all failed to
combine these three features, and often 2 of the 3 were missing.
We therefore sought to determine if adding in the ERK positive
feedback pathway would ﬁx this limitation and to see if such a
model would help address the paradox described above concerning
bimolecular vs. multimolecular pathways.
A great deal of effort building and testing such computational
models with ERK feedback added initially failed to reproduce the
3 essential features of the TCR response, no matter how much
we moved from abstracted and rather simple models with a few
components to more complex models with dozens of steps or we
varied the speciﬁc concentration and kinetic parameters. The
breakthrough came not from the computational trials themselves,
though they were important in indicating that some knowledge of
the T cell signaling system was missing, but from addition biolog-
ical experiments and a new method just introduced into the ﬁeld.
Up to this time, others and we analyzed signaling events using
Western blots that averaged the responses of thousands or millions
of single cells. The introduction of phosphoﬂowmethods [52] using
antibodies to the activated form of enzymes such as ERK allowed
single cell resolution in such analyses. Unexpectedly, when we
used phosphoﬂow to examine the ERK response of CD8+ T cells
to pMHC, we found that increasing the quantity of pMHC per pre-
senting cell did not lead to the expected gradual increase in aver-
age ﬂuorescence intensity of ppERK staining in all the T cells in
the responding population. Instead this dose titration caused an in-
crease in the number of T cells that each showed the same high
(70–80% of maximum) conversion of ERK to ppERK. That is, the
ERK response was digital on a per cell basis – a cell either remained
at a low baseline level of activated ERK or rapidly reached a peak
level of ppERK irrespective of the concentration of triggering
pMHC; changes in ligand density only affected the fraction of fully
responding cells. The triggered T cells were only found with an
intermediate amount of ppERK for a few minutes during the onset
of the response as they progressed from the resting state to the
fully activated state. This digital behavior, see previously using
transcriptional reporters in hybridoma cells [53] and veriﬁed since
by others at the biochemical level [54,55], has major implications
for understanding T cell responses. It implies that at low ligand
densities, some cells are fully activated, where a proportional sig-
naling model would imply that no cell is fully activated until much
higher densities of pMHC are available (Fig. 2). This digital behav-
ior of the MAPK pathway and its role in controlling switch-likebehavior in cells has been emphasized in seminal work from Ferrell
in non-immune biological systems [56,57].
Once this property of the ERK pathway in T cells was recognized
and encoded in the model, we were suddenly able to replicate
many of the essential features of the T cell response to ligand, in
particular the sharp transition between non-agonists and agonists
within a narrow range of biophysical binding parameters between
TCR and pMHC. This feature was something we were unable to
achieve in any model in which the ERK behavior was analog and
not digital [46]. With some parameter reﬁnement, this model
was able to predict a number of aspects of the T cell response to
antigen that experimental tests validated. These included the key
predictions that a modest drop in SHP-1 levels in a T cell would al-
low a previously non-stimulatory ligand to acquire agonist activity
without a change in the nature of its binding to the TCR, and that
ligands whose binding to the TCR more closely approximated that
of agonists would be more potent antagonists than weaker binding
ligands. This latter somewhat unexpected result is explained by
the increasingly strong generation of pSHP-1 by the better binding
ligands in the absence of a compensating ERK response, until the
threshold for transition to early digital ERK production is reached
and this addition of positive feedback overcomes the negative
inﬂuence of pSHP-1 generation. Finally, the model explained the
bimolecular – multimolecular paradox raised above. The SHP-1
negative feedback systems operates in an analog fashion, whereas
the ERK feedback is digital. With an agonist, there would be a small
amount of pSHP-1 generated and bound to TCRs before the explo-
sive ERK response ensues. This would begin to blunt the TCR re-
sponse, but by modifying all Lck molecules not yet engaged by
pSHP-1, an early burst of ERK protects the TCR signaling apparatus
from further negative regulation until ERK phosphatases reverse
the protection, as we see after 30–45 min of stimulation. Indeed,
a careful re-analysis of blots probing the binding of pSHP-1 to
Lck in the TCR complex showed just the predicted behavior. We
observed small amounts of pSHP-1 binding in the ﬁrst 1–2 min
after initiation of TCR engagement by agonist and then a failure
to accumulate any additional pSHP-1 until ERK activity decreased
and Lck shifted from the ERK-induced serine 59 phosphorylated
form [58] to the pSHP-1 receptive p56 form 30–45 min after sig-
naling began.
This new model allowed all three of the canonical TCR response
features to be reproduced in simulations and it also provided in-
sight into several previously unrecognized aspects of TCR signaling.
Biochemical support for this model, especially the role of ERK, can
be found in an important study involving miR-181a [59]. More re-
cently, the model was used to make several predictions about what
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would have on the T cell response. These studies predicted that
variations in CD8 would lead to a change in the EC50, whereas a
change in SHP-1 would affect the fraction of responding cells, with-
out altering the EC50 for the remaining responsive fraction, and
that variations in ERK would have no effect [60]. All three predic-
tions were borne out by ﬂow cytometry-based assays that permit-
ted assessment of ppERK induction in concert with measurement
of CD8, SHP-1, and ERK levels in the same cell. The cell to cell var-
iation in function revealed by these studies even within a puta-
tively homogenous TCR transgenic naïve T cell population is of
substantial signiﬁcance for our understanding of how distinct fates
of T cells arise during an immune response and also raises intrigu-
ing questions about the issues of robustness and sensitivity that
many models ﬁnd difﬁcult to reconcile. Our experiments suggest
the possibility that the cell tempers the effects of the cell to cell
variations and presumably, the temporal ﬂuctuation in protein
expression within a single cell, by counterbalancing the states of
components within a pathway so that the net output of the path-
way is maintained within acceptable levels; this pathway or net-
work balancing also would then permit an acute change in the
concentration or state of just a single component to unbalance
the network and lead to a response to even a small input.4. The future
4.1. Moving from ordinary differential equations (ODEs) to spatially-
resolved modeling
The model described above simulates all intra-cellular signaling
processes as if they would take place in a single, well-stirred bio-
chemical compartment. Hence, it does not take into account any
of the data showing a key role for protein localization and molec-
ular clustering on signaling by the TCR, or revealing a role for scaf-
folds in signal segregation and transmission. Furthermore, it does
not allow one to assess the role of microcluster formation or syn-
apse organization [20–23], issues some others have addressed in
models that incorporate our feedback information together with
spatial aspects of molecular behavior [61,62]. Finally, the lack of
spatial aspects precludes studying the relationship between T cell
signaling behavior and cell shape or dynamics, even though we
know that T cells are highly motile in the lymph node and periph-
ery [63–65] and data from studies of T–B collaboration clearly
show that functional cell interactions are affected strongly by
migratory dynamics and the duration of contact in vivo [66].
To address these issues and related issues of cell signaling in the
ﬁeld of immunology and more broadly in cell biology, we have be-
gun to develop a new suite of simulation technologies and soft-
ware tools to support detailed, spatially-resolved modeling in the
context of changing cell shape and migratory dynamics in complex
multicellular environments. These efforts are part of a computa-
tional systems biology effort in the Intramural Research Program
of NIAID called the Program in Systems Immunology and Infectious
Disease Modeling (PSIIM [http://www.niaid.nih.gov/labsandre-
sources/labs/aboutlabs/psiim/Pages/default.aspx]. Composed of
an integrated group of expert teams in the areas of immunology,
cell and molecular biology, computational modeling, systems
genomics, transcriptional networks, and proteomics, the PSIIM is
developing a set of approaches that can support its own speciﬁc re-
search agenda and also can provide biologists with a readily acces-
sible set of methods and tools for undertaking complex modeling
and simulation of their own systems of interest. The PSIIM is using
new methods for global RNAi screening to discover more complete
pathway and network connectivity for signaling systems such as
TLR, TCR, and chemokine receptors, employing advanced massspectrometry methods to permit absolute quantiﬁcation of num-
bers of molecules in a cell or cell subcompartment, developing
new ways to use multiplex SPR measurements to rapidly obtain
the reaction rates needed for parameterizing molecular interaction
network models, and creating novel software tools for modeling
and simulation [67–69]. It is also developing methods for translat-
ing confocal and 2-photon imaging data into computable cell
shapes and tissue environments [70,71], along with software tools
that permit integrating signaling models with spatial features of
the cell, and with the dynamic behavior of cells within a more
complex tissue setting.
4.2. The Simmune software environment for multiscale modeling
There are two major classes of obstacles to moving to more pre-
cise and inclusive models of (immune) cell function. The ﬁrst is the
need for a comprehensive computational framework that allows
the facile construction and simulation of spatially-resolved, multi-
scale models taking into account reaction-diffusion processes,
intracellular compartmentalization, and higher order behavior of
cells in complex tissue settings. The second is obtaining measure-
ments of a sufﬁcient number of parameters to reduce the degrees
of freedom in such models to a manageable level that limits com-
putational examination of biologically irrelevant conditions. The
PSIIM is organized around efforts to address both of these key
issues. M. Meier-Schellersheim and his group [http://www.niaid.
nih.gov/labsandresources/labs/aboutlabs/psiim/computationalbi
ology/Pages/simmuneproject.aspx] have developed a software
suite called Simmune that deals with the computational issues.
Simmune is designed to permit a biologist with detailed knowledge
of a particular system to construct and simulate desired aspects of
that biological systemwithout concern for the complex mathemat-
ics and computer programming issues that normally limit such ef-
forts [69]. Through a (reasonably intuitive) graphical users
interface, the biologist can develop a model of, for example,
trans-membrane signaling that is built from simple molecular
binding event inputs and deﬁnitions of molecular complexes and
transitions (Fig. 3). Based on such user deﬁnitions, the resulting
signaling network, that is, the list of all reactions that can take
place and lead to the formation of (multi-)molecular complexes,
is automatically constructed by the software. This has several ma-
jor beneﬁts – ﬁrst, assuming the binary molecular events are prop-
erly deﬁned during the input process, even very complex network
schemes will not contain user errors in connectivity; second, it is
simple to add or remove elements and run a new simulation, with-
out the risk of errors of mass balance or missing terms in equations
of the type normally written manually for such modeling, as this is
now done automatically and without error by the software; third,
the models are easily shared with others running the same soft-
ware and these other users can readily simulate different condi-
tions, change the model and test the effects of these changes,
combine models of modules with shared molecular components
and so on. Thus, Simmune eliminates many of the major impedi-
ments to the use of mathematical modeling and computer simula-
tion in biology – the barrier to the involvement of most biologists
lacking advanced mathematical or programming skills, the ‘one-
off’ nature of most models built by hand, the difﬁculty of changing
such manual models over time, and the difﬁculty of sharing and
integrating models that represent aspects of a larger biological sys-
tem. Simmune runs on commonly used computing platforms (Win-
dows, Mac, and Linux OS), and for models of modest size, does not
require supercomputing facilities for simulation.
In addition to the features already mentioned, Simmune in its
next version will have a more intuitive and visually sophisticated
user interface, so that biologists will ﬁnd model construction even
easier. The modeling software will also be linked to proteomic
Fig. 3. Screen shot of the user interface of Simmune2.0. The image shows how the software keeps track of the investigator’s entries of molecules and complexes (far left) and
provides a dynamic graphical view of the pathway being input with precise deﬁnition of the sites of interaction for molecules with multiple interaction sites (center panel).
Linked windows that are called up by highlighting speciﬁc entries in this window allow the user to input parameters for the molecules and complexes, such as numbers of
molecules, kinetic constants, and so on.
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ally entered and links retained to allow others to understand the
origins of elements of a model with respect to existing databases
on molecular interactions or the literature.
The early version of Simmune instantiated cells as geometric ob-
jects of limited shape diversity. Using new algorithms introduced
by M. Meier-Schellersheim and F. Klauschen, the software now is
able to simulate the activities of cells of diverse and realisticFig. 4. Illustration of the conversion of confocal 3D imaging data into discretized, compu
manner to an antigen-presenting B cell tumor. The image on the left shows the wire-fram
manner closer to the original confocal image. Red = T cell; green = B cell tumor.shapes, which can be automatically imported in computable form
from microscopic data, for example, a confocal microscope z-stack
(Fig. 4; [71]). The same methods also allow Simmune to generate
more complex cellular environments, including intracellular com-
partments like nuclei. They also permit placing cells in computa-
tional reconstructions of complex 3D extracellular environments
that we extract from 2-photon live intravital imaging studies per-
formed in the laboratory to examine cellular interactions [72], andtable versions of the imaged cells, in this case a T cell bound in an antigen-speciﬁc
e version of discretized space; the rendered version on the right shows the cells in a
4820 R.N. Germain / FEBS Letters 584 (2010) 4814–4822soon, the spatially-resolved signaling dynamics of immune cells in
the living animal.
To allow researchers to deﬁne and explore aspects of cellular
behavior that involve combinations of processes on very diverse
time scales Simmune also allows simulations using a hybrid agent
approach in which higher order cell state changes, such as division,
death, differentiation or motion, can be coupled to ﬁne-grained
biochemical simulations through rules formulated in terms of
threshold molecular concentrations triggering those state changes.
In this realm, Simmune does not operate in a Boolean manner with
only two alternative states of the agent, but uses continuous func-
tions so that although based on rules that use Boolean arguments
such as ‘and’, ‘or’ and so on, the results better reﬂect the variation
of functionality characteristic of a biological system, which is not
typically binary in its behavior. In addition, the hybrid agent as-
pects of Simmune models can be directly linked to the ﬁne-grained
molecular simulations, with each feeding into the other as a simu-
lation progresses.
Finally, Simmune also has a capacity to connect simulation of
cellular biochemistry with simulations of cell shape changes and
migratory dynamics, allowing models to be built that can address
the behavior of immune cells within lymphoid or peripheral tissue
environments, and permitting the models and simulations to pre-
dict outcomes that can be explored using intravital imaging tools.
Thus, in single software suite, an investigator can go from a de-
tailed analysis of biochemical events involved in signal transduc-
tion, to gene expression (using the agent based rules modeling),
to control of cell polarity and shape, and on to the activity of many
such cells in a complex extracellular or multicellular environment.
Whereas other software tools for modeling and simulation imple-
ment some of the key elements of Simmune (these include BioNet-
Gen [http://bionetgen.org/index.php/Main_Page] for automated
generation of signaling networks and the Virtual Cell [http://
www.ibiblio.org/virtualcell/] for spatially-resolved simulations),
Simmune’s strength lies in the combination of elements described
here in terms of its integrated capacity to model across many spa-
tial and temporal scales in a facile manner.
4.3. A technological infrastructure for data acquisition to support
multiscale modeling
While Simmune provides the computational infrastructure for
advanced modeling and simulation, it would be difﬁcult to employ
its power effectively without the right kinds of data to constrain
the parameters that go into constructing such models. For simula-
tion of biochemical signaling pathways, it is important to be as
complete as possible in deﬁning the relevant members of the mod-
ule to be modeled and the biochemical transformations these mol-
ecules undergo following a stimulation event. This means reducing
to the greatest extent gaps in knowledge on molecular connectiv-
ity, obtaining information on parameters such as association and
dissociation constants, measuring catalytic rates, and quantifying
total protein amounts. I. Fraser and his group within the
PSIIM [http://www.niaid.nih.gov/LabsAndResources/labs/aboutl-
abs/psiim/Pages/MolecularCellBiologyGroup.aspx] are focused on
the ﬁrst of these issues, using high content, highly multiplex
(including full genome) RNAi screening in the context of relevant
receptor stimulation events in the cell type of interest (for exam-
ple, TCR in T cells, TLR in macrophages) to help better deﬁne the
membership in the pathways/networks to be simulated. This team
and also that of A. Nita-Lazar [http://www.niaid.nih.gov/LabsAn-
dResources/labs/aboutlabs/psiim/Pages/proteomics.aspx] is using
proteomic and protein biochemical tools such as mass spectrome-
try and surface plasmon resonance, also in high-throughput, mul-
tiplex mode, to rapidly quantify the absolute numbers of each
molecule present in a particular cell type and to be included in amodel, as well as to measure Kas and Kds for the interactions of
these molecules. This group will also assess post-translational
modiﬁcations that arise as a result of receptor engagement. To en-
hance the rate of data acquisition for binding parameters, we are
exploring the possibility of using linked transcription-translation
with on-chip puriﬁcation [73] in microﬂuidic-based analytic de-
vices, to avoid laborious expression and puriﬁcation schemes bet-
ter suited to individual proteins and not the dozens of components
included in models of the type we are seeking to build on an ongo-
ing basis. Likewise, we will take advantage of the latest advances in
mass spectrometry-based quantiﬁcation that combine computa-
tional methods [74] with isotope-labeled peptide reconstructions
and reaction monitoring schemes [75], to also improve the rate
and the completeness with which such data can be gathered. The
PSIIM will also use advanced microscopic methods to gain insight
into the spatial distribution of molecules of interest and how this
distribution changes over time post-stimulation of cellular recep-
tors, using ultrahigh resolution in vitro analysis and also intravital
dynamic imaging.
Through these technologies, it will be possible to construct spa-
tially-resolved models based much more on hard data than guesses
for parameter values, markedly constraining the degrees of free-
dom in such simulations. This in turn should yield outputs closer
to what will be observed in experimental measurements of the sys-
tem, enhancing the ‘experiment – model building – simulation
– prediction – experiment – model improvement – simulation
– experiment’ virtuous cycle that lies at the heart of modern com-
putational system biology efforts to advance biomedicine. The
implementation of this paradigm using the new, integrated, multi-
plex experimental and computational tools described above should
yield a reﬁned model of TCR signaling and ligand discrimination in
the near future that will markedly advance our understanding of
this still intriguing aspect of immunobiology.
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